Page last updated: 2024-09-05

1,2-didodecanoyl-glycero-3-phosphocholine and Breast Neoplasms

1,2-didodecanoyl-glycero-3-phosphocholine has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, SS; Liu, Y; Pan, J1

Other Studies

1 other study(ies) available for 1,2-didodecanoyl-glycero-3-phosphocholine and Breast Neoplasms

ArticleYear
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    International journal of pharmaceutics, 2010, Aug-16, Volume: 395, Issue:1-2

    Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Humans; Inhibitory Concentration 50; Kinetics; Lactic Acid; Light; Microscopy, Electron, Scanning; Nanoparticles; Paclitaxel; Particle Size; Phosphatidylglycerols; Photoelectron Spectroscopy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Scattering, Radiation; Solubility; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical

2010